Data / Drug companies / Medi-Physics Inc. DBA GE Healthcare
Medi-Physics Inc. DBA GE Healthcare: 11 products in the FDA NDC directory, labeler code 17156
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Medi-Physics Inc. DBA GE Healthcare (labeler code 17156) lists 11 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 9 prescription drugs, 2 bulk ingredients. Its main marketing category is new drug applications (NDA). The newest product started marketing on September 25, 2018.
The request: Watch Medi-Physics Inc. DBA GE Healthcare (FDA labeler code 17156): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 17156
- Products in commercial distribution
- 11
- Packages
- 11
- Finished drugs by generic name
- 8
- Prescription products
- 9
- Over the counter products
- 0
- Flagged as original packager
- 9 of 9 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- February 18, 1982
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 9 | 81.8% |
| Bulk ingredients | 2 | 18.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 9 | 81.8% |
| Bulk ingredients | 2 | 18.2% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Tetrofosmin | 2 | 1 |
| Technetium tc-99m exametazime and cobaltous chloride | 1 | 1 |
| Flutemetamol f-18 | 1 | 1 |
| Iobenguane i-123 | 1 | 1 |
| Indium in-111 oxyquinoline | 1 | 2 |
| Indium in-111 pentetate disodium | 1 | 1 |
| Ioflupane i-123 | 1 | 2 |
| Technetium tc-99m exametazime | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 5 | 45.5% |
| Injection, powder, lyophilized, for solution | 3 | 27.3% |
| Kit | 1 | 9.1% |
| Injection | 1 | 9.1% |
| Injection, solution | 1 | 9.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Radioactive Diagnostic Agent | 3 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ceretec | 17156-025 | Kit | New drug applications (NDA) | September 25, 2018 |
| Vizamyl | 17156-067 | Solution | New drug applications (NDA) | January 1, 2014 |
| Sodium thiosulfate | 17156-946 | Solution | Bulk ingredients | July 1, 2013 |
| Sodium iodide i-123 | 17156-945 | Solution | Bulk ingredients | July 1, 2013 |
| DaTscan | 17156-210 | Injection, solution | New drug applications (NDA) | March 1, 2011 |
| Myoview | 17156-026 | Injection, powder, lyophilized, for solution | New drug applications (NDA) | February 26, 2009 |
| AdreView | 17156-235 | Injection | New drug applications (NDA) | September 19, 2008 |
| Myoview | 17156-024 | Injection, powder, lyophilized, for solution | New drug applications (NDA) | February 9, 1996 |
| Ceretec | 17156-022 | Injection, powder, lyophilized, for solution | New drug applications (NDA) | December 30, 1988 |
| Indium in 111 Oxyquinoline | 17156-021 | Solution | New drug applications (NDA) | December 1, 1985 |
| Indium DTPA In 111 | 17156-251 | Solution | New drug applications (NDA) | February 18, 1982 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.